LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in LianBio as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- −1 vs. Q2 2023
- Shares held
- 79.0M
- −1.20M (−1.5%) vs. Q2 2023
- Total value
- $117.7M
- −$65.2M (−35.6%) vs. Q2 2023
- New holders
- 6
- 8 more added
- Sold out
- 7
- 7 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LIANY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $1.00K |
| Q1 2026 | 1 | $1.00K |
| Q4 2025 | 1 | $1.00K |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $5.00K |
| Q1 2025 | 1 | $2.00K |
| Q4 2024 | 2 | $42.1K |
| Q3 2024 | 2 | $47.3K |
| Q2 2024 | 2 | $50.5K |
| Q1 2024 | 3 | $49.2K |
| Q4 2023 | 29 | $377.3M |
| Q3 2023 | 38 | $117.7M |
| Q2 2023 | 39 | $182.9M |
| Q1 2023 | 36 | $157.1M |
| Q4 2022 | 40 | $133.3M |
| Q3 2022 | 44 | $168.0M |
| Q2 2022 | 44 | $187.1M |
| Q1 2022 | 37 | $318.6M |
| Q4 2021 | 36 | $550.5M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding LianBio; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 86 | $128 | 0.00% | +86 | New |
| Cary Street Partner Investment Advisory LLC | 1,000 | $1.49K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,001 | $1.49K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 10,563 | $15.0K | 0.00% | +10,563 | New |
| Commonwealth Equity Services, LLC | 10,830 | $16.0K | 0.00% | −6,000−35.7% | Reduced |
| Bank of America Corp | 11,847 | $17.7K | 0.00% | +837+7.6% | Added |
| Susquehanna International Group, LLP | 12,175 | $18.1K | 0.00% | +12,175 | New |
| Donald L. Hagan, LLC | 15,000 | $22.4K | 0.01% | 00.0% | Unchanged |
| Axxcess Wealth Management, LLC | 16,590 | $24.7K | 0.00% | +16,590 | New |
| Stifel Financial Corp | 18,034 | $26.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 19,494 | $29.0K | 0.00% | 00.0% | Unchanged |
| Exchange Traded Concepts, LLC | 27,778 | $41.4K | 0.00% | 00.0% | Unchanged |
| Old Well Partners, LLC | 32,200 | $48.0K | 0.04% | 00.0% | Unchanged |
| Shay Capital LLC | 36,332 | $54.1K | 0.02% | +36,332 | New |
| SG Americas Securities, LLC | 58,541 | $87.0K | 0.00% | 00.0% | Unchanged |
| Cornercap Investment Counsel Inc | 101,039 | $150.5K | 0.03% | −1,198−1.2% | Reduced |
| Landscape Capital Management, L.L.C. | 131,641 | $196.1K | 0.03% | +131,641 | New |
| Manufacturers Life Insurance Company, The | 134,184 | $199.9K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 181,144 | $268.0K | 0.00% | +38,808+27.3% | Added |
| Millennium Management LLC | 196,313 | $292.5K | 0.00% | +103,666+111.9% | Added |
| MYDA Advisors LLC | 200,000 | $298.0K | 0.11% | +62,149+45.1% | Added |
| Casdin Capital, LLC | 206,415 | $307.6K | 0.03% | 00.0% | Unchanged |
| Logos Global Management LP | 280,000 | $417.2K | 0.06% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 282,602 | $421.0K | 0.00% | −25,898−8.4% | Reduced |
| TD Asset Management Inc | 357,038 | $532.0K | 0.00% | +178,519+100.0% | Added |
| Citadel Advisors LLC | 507,806 | $756.6K | 0.00% | +381,749+302.8% | Added |
| BlackRock Inc. | 615,188 | $916.6K | 0.00% | −381,155−38.3% | Reduced |
| Citigroup Inc | 615,940 | $917.8K | 0.00% | −91,396−12.9% | Reduced |
| Affinity Asset Advisors, LLC | 672,357 | $1.00M | 0.33% | −128,319−16.0% | Reduced |
| SCHF (Gpe), LLC | 937,500 | $1.40M | 25.49% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,800,000 | $2.68M | 0.38% | +837,978+87.1% | Added |
| 22NW, LP | 2,211,678 | $3.30M | 2.45% | +2,070,455+1,466.1% | Added |
| Vida Ventures Advisors, LLC | 2,282,084 | $3.40M | 5.26% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,598,766 | $3.87M | 0.00% | −111,448−4.1% | Reduced |
| Tybourne Capital Management (HK) Ltd | 3,303,573 | $4.92M | 0.69% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 3,564,173 | $5.31M | 0.02% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 57,558,451 | $85.8M | 2.88% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −4,250,000−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −32,500−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −22,297−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −19,432−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,848−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −878−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −100−100.0% | Sold out |